Viruses, start your engines!December 30, 2008Researchers find what drives one of nature's powerful, nanoscale motors Peering at structures only atoms across, researchers have identified the clockwork that drives a powerful virus nanomotor. Because of the motor's strength--to scale, twice that of an automobile--the new findings could inspire engineers designing sophisticated nanomachines. In addition, because a number of virus types may possess a similar motor, including the virus that causes herpes, the results may also assist pharmaceutical companies developing methods to sabotage virus machinery. Researchers from Purdue University in West Lafayette, Ind., and the Catholic University of America in Washington, D.C., collaborated on the study that appears in the Dec. 26, 2008, issue of the journal Cell. "The discovery of how this virus motor functions represents a significant milestone in the investigation of viral processes," says David Rockcliffe, the program director who oversees a National Science Foundation (NSF) grant that partly funded the research. "This research is a breakthrough that not only may lead to the development of a means of arresting harmful infections, but it also points to possible ways in which nano-devices could be fashioned," The virus in the study, called T4, is not a common scourge of people, but its host is: the bacterium Escherichia coli (E. coli). Purdue researchers studied the virus structures, such as the motor, while the Catholic University researchers isolated the virus components and performed biochemical analyses. "T4 is what's called a 'tailed virus'," says Purdue biologist Michael Rossmann, one of the lead researchers for the study. "It is actually one of the most common types of organisms in the oceans of the world. There are many different, tailed, bacteria viruses--or phages--and all of these phages have such a motor for packaging their DNA, their genome, into their pre-formed heads." The virus is well known to scientists. "T4 has rich history going back to 1940s when the original genetic tools to understand virus assembly were developed," adds biologist Venigalla Rao of Catholic University, also a lead researcher on the study. "T4 has been an important model system to tease out the details of basic mechanisms by which viruses assemble into infectious particles." For the recent study, analyses involved two sophisticated instruments capable of studying structures at the nanometer (billionth of a meter) scale. One of the techniques, x-ray crystallography, showed the ordered arrays of atoms in the various structures, while another, called cryo-electron microscopy, let the researchers study the broader shape of the structures without the need for coating or drying out the specimens. Having already determined the structures of a number of other viral components and how they self-assemble, in this study the researchers focused their attention on the small motor that some viruses use to package DNA into their "heads", protein shells also called capsids. Not all viruses have a motor such as the one found in the T4 virus, but some viruses that cause human diseases posses molecular motors with similar functions, and likely have similar structures. T4 uses its motor to pack about 171,000 basepairs of genetic information to near-crystalline density within its 120 nanometer by 86 nanometer capsid. The researchers found that the motor is located at the intersection of the capsid and the virus "tail" and is made of a circular array of proteins called gene product 17 (gp17). Five, two-part, gp17 proteins combine to form a pair of conjoined rings, arrayed so that their upper segments form an upper ring and their lower segments form a lower ring. As a T4 virus assembles itself, the lower ring of the motor structure attaches to a strand of DNA, while the upper ring attaches to a capsid. The upper and lower rings have opposite charges, which allow the motor to contract and release, alternately tugging at the DNA like a ring of hands pulling on a rope. The process draws the DNA strand upwards into the capsid where it is protected from damage, enabling the virus to survive and reproduce. After the DNA is inside the capsid, the motor falls off, and a virus tail attaches to the capsid. Until now, researchers did not know how T4, or any other virus, accomplished the DNA packaging. According to Rao, "Since the assembly of herpes viruses closely resembles that of T4, this research might provide insights on how to manipulate herpes infections." While many questions remain, adds Rossmann, the virus may lend itself to a variety for medical purposes. One example Rossmann cites is as a potential new weapon to fight dangerous microbes. "Bacteriophages like T4 are a completely alternative way of dealing with unwanted bacteria. The virus can kill bacteria in its process of reproduction, so use of such viruses as antibiotics has been a long looked-for alternative to overcome the problems which we now have with antibiotics." National Science Foundation |
|||||||||||||||||||||
| Related Virus Current Events and Virus News Articles 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. When should flu trigger a school shutdown? As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down? Common Pain Relievers May Dilute Power of Flu Shots With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system. PMH finding may help some tonsil cancer patients avoid chemotherapy Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. Immune therapy can protect against or treat later lymphoma Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection. Study reveals a 'missing link' in immune response to disease The immune system's T cells have the unique responsibilities of being both jury and executioner. They examine other cells for signs of disease, including cancers or infections, and, if such evidence is found, rid them from the body. Precisely how T cells shift so swiftly from one role to another, however, has been a mystery. Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. Breakthrough in fight against Hendra virus There has been a breakthrough in the fight against the deadly Hendra virus following the development of a treatment which shows great potential to save the lives of people who become infected with the virus. USU scientists report major advance in human antibody therapy against deadly Nipah virus A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus. More Virus Current Events and Virus News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||